Syndrome métabolique : quelle définition pour quel(s) traitement(s) ?-Reference-Cited by-同舟云学术

Syndrome métabolique : quelle définition pour quel(s) traitement(s) ?

Published:2005-12 Issue:12 Volume:21 Page:1045-1053
ISSN:0767-0974
Container-title:médecine/sciences
language:
Short-container-title:Med Sci (Paris)

Author:

Junquero Didier,Rival Yves

Publisher

EDP Sciences

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.medecinesciences.org/10.1051/medsci/200521121045/pdf

Reference42 articles.

1. Reaven GM. Role of insulin resistance in human disease.Diabetes1988; 37 : 1595–607.

2. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxydant treatment during pregnancy influencein uteroprogramming and postnatal susceptibility to atherogenesis.FASEB J2002; 16 : 1348–60.

3. Alberti KGMM, Zimmet PZ. For the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation.Diabet Med1998; 15 : 539–53.

4. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report on the National cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III).JAMA2001; 285 : 2486–97.

5. The European group for the study of insulin resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts and an alternative definition of an insulin resistance syndrome.Diabetes Metab2002; 28 : 364–76.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of the metabolic syndrome and its components in secondary school student population in the city of Douala, Cameroon;Journal of Public Health in Africa;2023-08-29

2. Frequency of Metabolic Syndrome and Study of Anthropometric, Clinical and Biological Characteristics in Peri- and Postmenopausal Women in the City of Ksar El Kebir (Northern Morocco);International Journal of Environmental Research and Public Health;2022-05-17

3. Catestatin peptide of chromogranin A as a potential new target for several risk factors management in the course of metabolic syndrome;Biomedicine & Pharmacotherapy;2021-02

4. Analysis of risk factors of metabolic syndrome using a structural equation model: a cohort study;Endocrine;2018-08-21

5. PiT1 : du transport de phosphate à la signalisation insulinique;médecine/sciences;2017-05